Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

N,N-Dimethyltryptamine - Viridia Life Sciences

Next Previous
Drug Profile

N,N-Dimethyltryptamine - Viridia Life Sciences

Alternative Names: buccal film DMT; N,N-Dimethyltryptamine; VLS-01; VLS-01-BU

Latest Information Update: 11 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ATAI Life Sciences; IntelGenx Corp.
  • Developer Atai Beckley
  • Class Antidepressants; Antipsychotics; Dimethylamines; Drug withdrawal therapies; Neuropsychotherapeutics; Small molecules; Tryptamines; Vascular disorder therapies
  • Mechanism of Action Serotonin 1A receptor partial agonists; Serotonin 2A receptor partial agonists; Serotonin 2C receptor partial agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Treatment-resistant depressive disorder

Most Recent Events

  • 05 Nov 2025 ATAI Life Sciences has merged with Beckley Psytech to form Atai Beckley
  • 01 May 2025 N,N-Dimethyltryptamine is covered by patent protection worldwide
  • 30 Dec 2024 Phase-II clinical trials in Treatment resistant depressive disorder in USA (Buccal) (NCT06524830)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top